Bridgebio Oncology Therapeutics, Inc. (BBOT) — 10-Q Filings

10-Q Filings (6)

• 10-Q Filing — Nov 12, 2025
• Helix Acquisition Corp. II Continues SPAC Hunt, No Revenue Reported — Aug 1, 2025 Risk: high
  Helix Acquisition Corp. II (BBOT) reported no revenue for the quarter ended June 30, 2025, consistent with its status as a Special Purpose Acquisition Company (
• Helix Acquisition Corp. II Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Helix Acquisition Corp. II filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in the Cayman Islands and mana
• Helix Acquisition Corp. II Files Q3 2024 10-Q — Nov 14, 2024 Risk: low
  Helix Acquisition Corp. II filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, incorporated in the Cayman Islands, is
• Helix Acquisition Corp. II Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
  Helix Acquisition Corp. II filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, incorporated in the Cayman Islands, is a bla
• Helix Acquisition Corp. II Files 10-Q for Quarter Ended March 31, 2024 — May 15, 2024 Risk: low
  Helix Acquisition Corp. II (BBOT) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Helix Acquisition Corp. II filed a Form 10-Q for the quarterly p

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX